Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
-
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
-
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
-
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
-
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
HEMATOLOGIC CANCER NEWS
Next post in Hematologic Cancers
Loading...
Loading...